iSTAR Medical initiates international STAR-VI trial for the use of MINIject in conjunction with cataract surgery

MINIject® is the only commercially available MIGS implant targeting the supraciliary space Clinical data show positive, consistent results up to two-year follow-up in patients across Europe, Asia

Related Keywords

United States ,Wavre ,Waals Gewest ,Belgium ,America ,Dennis Riedl ,Mahmoud Radwan ,Chris Welsh ,Iqbal Ikek Ahmed ,Amber Fennell ,Michel Vanbrabant ,Paul Van Hagen ,University Of Utah United States ,Colchester Eye Centre ,Department Of Ophthalmology ,Prism Eye Institute ,Consilium Strategic Communications ,Iqbal Ike ,Visual Sciences ,Chief Innovation Officer ,Consultant Ophthalmologist ,United Kingdom ,Financial Officer ,Distar ,Medical ,Nitiates ,Nternational ,Star ,Trial ,Iniject ,Conjunction ,Cataract ,Surgery ,